DarioHealth
New York
About DarioHealth
DarioHealth is a digital health company. It is engaged in the development and commercialization of patented and proprietary technology that provides consumers with laboratory-testing capabilities using smartphones and other mobile devices. The company's product, Dario Blood sugar monitor is a mobile, real-time, cloud-based, diabetes management solution based on a multi-featured software application combined with a blood glucose monitoring device. The group operates internationally and derives revenues from the sale of its Dario smart meter and related device-specific disposables test strip cartridges and lancets. The company generates the majority of the revenue.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $320.5M
- Funding stage: IPO
- Last round: Post-IPO Equity (Sep 2025)
- Ticker: nasdaq:DRIO
- Website: dariohealth.com
- Phone: 646-259-3321
Industries & Categories
Health Care, Health Diagnostics, Medical Device, Software, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/dariohealth-21496 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.